4.5 Article

Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin

Journal

FEBS LETTERS
Volume 484, Issue 2, Pages 87-91

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/S0014-5793(00)02131-1

Keywords

aptamer; serpin; thrombin; heparin cofactor II; antithrombin

Funding

  1. NHLBI NIH HHS [HL32656, 1K08HL04063] Funding Source: Medline

Ask authors/readers for more resources

'Thrombin aptamers' are based on the 15-nucleotide consensus sequence of d(GGTTGGTGTGGTTGG) that binds specifically to thrombin's anion-binding exosite-I. The effect of aptamer-thrombin interactions during inhibition by the serine protease inhibitor (serpin) heparin cofactor II (HCII) and antithrombin (AT) has not been described. Thrombin inhibition by HCII without glycosaminoglycan was decreased similar to two-fold by the aptamer, In contrast, the aptamer dramatically reduced thrombin inhibition by > 200-fold and 30-fold for HCII-heparin and HCII-dermatan sulfate, respectively. The aptamer had essentially no effect on thrombin inhibition by AT with or without heparin, These results add to our understanding of thrombin aptamer activity for potential clinical application, and they further demonstrate the importance of thrombin exosite-I during inhibition by HCII-glycosaminoglycans. (C) 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available